Integrated Pathology Partnerships
Integrated Pathology Partnerships (iPP) was established in
2010 to work in partnership with the NHS to deliver
transformed pathology testing services in the UK. iPP now
conducts more than 25 million tests per annum and employs
over 650 staff across nine sites in the UK.
specifically established to enable UK healthcare
organisations to strengthen the quality, efficiency and
cost-effectiveness of their pathology services.
combined operational expertise and scientific leadership of
iPP equip it to be a strategic partner to both the NHS and
independent healthcare providers. We can assist a wide
variety of healthcare providers and commissioners in meeting
the challenges of quality, cost and rising demand in UK
iPP is a
team with a proven track record and unrivalled credentials.
It is the first company to truly demonstrate the
improvements that can be delivered through a hub and spoke
model. iPP also has the unique expertise of being able to
deliver transformation in a fast and efficient manner whilst
maintaining and enhancing the existing pathology operations.
The principle of making a positive difference to patient
care is at the heart of our business ethos.
offers a full range of diagnostic tests and services ranging
from phlebotomy, routine and urgent tests through to the
launch of cutting edge molecular diagnostics. Since its
inception, iPP has formed joint venture partnerships with
five NHS Foundation Trusts in Taunton, Yeovil, Southend,
Basildon and the Christie in Manchester. Joint venture
partnerships ensure that the service remains governed by
clinicians and senior executives from the hospital Trusts
and ensure that the service meets the demands of its
customers from primary care through to A&E. In addition, we
work in close collaboration with GP stakeholders to improve
service delivery including improved access to community
testing, point of care testing and phlebotomy.
part of the Synlab Group which offers laboratory services
across 35 countries.
Within the UK, the Group has recently expanded into
the specialist food, drug and alcohol testing sector through
the acquisition of Synergy Health Laboratory Services
(including Genon Laboratories) in Yorkshire and Abergavenny,
Wales. It also
continues to provide renal pathology testing services at its
Pathology First is iPP’s second joint venture collaboration.
It was formed in 2014 in partnership with Southend
University Hospital NHS Foundation Trust and Basildon and
Thurrock University Hospitals NHS Foundation Trust.
Pathology First delivers full laboratory services to a
population of 750,000 patients and over 100 GP practices in
the South East.
Pathology First brings together the skills and experience of
its partners and their parent companies to strengthen the
quality, delivery and efficiency of pathology services,
modern, refurbished, central laboratory in Basildon which
opened in February
· new, state of the art equipment;
optimised layouts that ensure the most efficient use of time
industry tested, robust IT systems that are fully integrated
between laboratories and referral sites; and
deployment of international best working practices that
deliver efficiency savings.
Pathology First operates a robust, clinically led,
integrated governance structure to deliver services across
multiple trusts. Our quality management system ensures our
analytical procedures are of the highest quality. Like iPP,
the principle of making a positive difference to patient
care is at the heart of the Pathology First business ethos.
We are committed to fully supporting pathology as a world
class discipline that plays a key role in meeting the NHS
goals of clinical integration and patient pathways.
The laboratory is registered by
the Health Care Professions Council as a training laboratory
and regularly undergoes inspections by accreditation
agencies including UKAS previously using the CPA standards
and now in transition to the new ISO:15189 2012 standards,
the Medicines and Healthcare Products Regulatory Agency
(MHRA), the Human Tissue Authority (HTA) and the Health and
Safety Executive (HSE). The Cytology department is fully
assessed by the NHSCSP (National Health Service Cervical
Screening Programme). These agencies assess the laboratory
against standards of all aspects of safety, quality and
In the past with CPA, accreditation was
conferred on the whole laboratory (or department) and all
the tests carried out within that laboratory. However with
UKAS, using the ISO 15189:2012 standards, it is tests that
are accredited not laboratories. Therefore any changes to
test or analyser platforms or the addition of new tests that
occur between UKAS assessment visits may result in the test
no longer be accredited until it has been assessed. As a
result of this a patient report may contain a mixture of
accredited and non-accredited results
aims to be clear and transparent to all users as to the
accreditation status of the tests they request and this
information can be found on the Schedules of Accreditation
that appear on the UKAS website. Below is a link to the UKAS
website and also to the Pathology First Policy on
Accreditation Status which explains this in more detail and
also describes how to access the Schedules of tests that are
currently UKAS accredited.
Pathology First Policy for the Notification to Users of UKAS
Pathology First services are provided from Southend and
Basildon Hospital and a Hub Laboratory. There is a single IT
system and regular courier service operating between all